Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
  • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
  • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P13/00—Drugs for disorders of the urinary system
  • A61P13/12—Drugs for disorders of the urinary system of the kidneys
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
  • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
  • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
  • C07K5/06—Dipeptides
  • C07K5/06008—Dipeptides with the first amino acid being neutral
  • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
  • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Molecular Biology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Cardiology (AREA)
• Epidemiology (AREA)
• Biochemistry (AREA)
• Biophysics (AREA)
• Genetics & Genomics (AREA)
• Heart & Thoracic Surgery (AREA)
• Urology & Nephrology (AREA)
• Hospice & Palliative Care (AREA)
• Vascular Medicine (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Peptides Or Proteins (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (4)

Publications (1)

Family

ID=55969107

Family Applications (1)

Country Status (32)

Families Citing this family (4)

Family Cites Families (3)

• 2016
  • 2016-05-02 US US15/568,575 patent/US20180155336A1/en not_active Abandoned
  • 2016-05-02 ES ES16722584T patent/ES2744227T3/es active Active
  • 2016-05-02 SG SG11201708747PA patent/SG11201708747PA/en unknown
  • 2016-05-02 HU HUE16722584 patent/HUE044787T2/hu unknown
  • 2016-05-02 EA EA201792422A patent/EA201792422A1/ru unknown
  • 2016-05-02 LT LTEP16722584.6T patent/LT3292133T/lt unknown
  • 2016-05-02 JP JP2017557439A patent/JP2018516882A/ja active Pending
  • 2016-05-02 CU CUP2017000136A patent/CU20170136A7/xx unknown
  • 2016-05-02 MX MX2017014134A patent/MX2017014134A/es unknown
  • 2016-05-02 PE PE2017002369A patent/PE20180204A1/es unknown
  • 2016-05-02 PL PL16722584T patent/PL3292133T3/pl unknown
  • 2016-05-02 MA MA042039A patent/MA42039A/fr unknown
  • 2016-05-02 HR HRP20191596 patent/HRP20191596T1/hr unknown
  • 2016-05-02 PT PT16722584T patent/PT3292133T/pt unknown
  • 2016-05-02 WO PCT/EP2016/059779 patent/WO2016188711A1/de not_active Ceased
  • 2016-05-02 BR BR112017023852-7A patent/BR112017023852A2/pt not_active Application Discontinuation
  • 2016-05-02 EP EP16722584.6A patent/EP3292133B1/de active Active
  • 2016-05-02 SI SI201630320T patent/SI3292133T1/sl unknown
  • 2016-05-02 UY UY0001036664A patent/UY36664A/es not_active Application Discontinuation
  • 2016-05-02 TN TNP/2017/000466A patent/TN2017000466A1/en unknown
  • 2016-05-02 CA CA2984984A patent/CA2984984A1/en not_active Abandoned
  • 2016-05-02 DK DK16722584.6T patent/DK3292133T3/da active
  • 2016-05-02 HK HK18105816.1A patent/HK1246290A1/zh unknown
  • 2016-05-02 AU AU2016268920A patent/AU2016268920A1/en not_active Abandoned
  • 2016-05-02 CN CN201680026200.1A patent/CN107531688A/zh active Pending
  • 2016-05-02 KR KR1020177033435A patent/KR20180002698A/ko not_active Withdrawn
  • 2016-05-04 TW TW105113790A patent/TW201713651A/zh unknown
• 2017
  • 2017-10-23 IL IL255208A patent/IL255208A0/en unknown
  • 2017-10-31 EC ECIEPI201772780A patent/ECSP17072780A/es unknown
  • 2017-11-02 CL CL2017002764A patent/CL2017002764A1/es unknown
  • 2017-11-02 CO CONC2017/0011294A patent/CO2017011294A2/es unknown
  • 2017-11-03 PH PH12017502010A patent/PH12017502010A1/en unknown

Also Published As

Similar Documents